P

Inventor

GLOVER NICHOLAS RONALD

CA13 patents
⚠️ This page may combine multiple inventors who share the name “GLOVER NICHOLAS RONALD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV ZUERICH

4 patents
US9259484B2Feb 16, 2016

Methods for treating cancer using an immunotoxin

UNIV ZUERICH4 citations80
US11713351B2Aug 1, 2023

Immunotoxin for treating cancer

UNIV ZUERICH0 citations58
US11713352B2Aug 1, 2023

Immunotoxin for treating cancer

UNIV ZUERICH0 citations58
US10858429B2Dec 8, 2020

Methods for treating cancer using an immunotoxin

UNIV ZUERICH0 citations48

MERCK PATENT GMBH

2 patents
US7339031B2Mar 4, 2008

Modified bouganin proteins, cytotoxins and methods and uses thereof

MERCK PATENT GMBH11 citations82
US7750136B2Jul 6, 2010

Modified bouganin proteins, cytotoxins and methods and uses thereof

MERCK PATENT GMBH4 citations61

GLOVER NICHOLAS RONALD

2 patents
US8084576B2Dec 27, 2011

Cancer associated glucose transporter 8 variant

GLOVER NICHOLAS RONALD2 citations57
US8697075B2Apr 15, 2014

Cancer specific antibody and cell surface proteins

GLOVER NICHOLAS RONALD0 citations46

VIVENTIA BIOTECHNOLOGIES INC

1 patent
US8383117B2Feb 26, 2013

CD44E tumor specific antibody

VIVENTIA BIOTECHNOLOGIES INC12 citations79

ZANGEMEISTER-WITTKE UWE

1 patent
US8545840B2Oct 1, 2013

Methods for treating cancer using an immunotoxin

ZANGEMEISTER-WITTKE UWE4 citations65

BAKER MATTHEW

1 patent
US8716234B2May 6, 2014

Cytotoxins comprising modified bouganin toxin for the treatment of cancer

BAKER MATTHEW1 citations60

VIVENTIA BIO INC

1 patent
US8969540B2Mar 3, 2015

Tumor specific antibody

VIVENTIA BIO INC0 citations46

SCHWARTZ MITTELMAN ADRIAN

1 patent
US9109223B2Aug 18, 2015

Methods for generating and screening fusion protein libraries and uses thereof

SCHWARTZ MITTELMAN ADRIAN0 citations31